Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia.

Salmon, Jessica M; Bots, Michael; Vidacs, Eva; Stanley, Kym L; Atadja, Peter; Zuber, Johannes; Johnstone, Ricky W

Salmon, Jessica M; Bots, Michael; Vidacs, Eva; Stanley, Kym L; Atadja, Peter; Zuber, Johannes; Johnstone, Ricky W.

Afiliación

Salmon JM; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC, 3002, Australia.
Bots M; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia.
Vidacs E; Laboratory of Clinical Chemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Stanley KL; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC, 3002, Australia.
Atadja P; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC, 3002, Australia.
Zuber J; China Novartis Institutes for Biomedical Research, No. 2 BoYun Road, Pudong, Shanghai, 201203, China.
Johnstone RW; Research Institute of Molecular Pathology (IMP), Dr. Bohr-Gasse 7, A-1030, Vienna, Austria.

Clin Epigenetics ; 12(1): 178, 2020 Nov 18.

Article en En | MEDLINE | ID: mdl-33208184

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Clin Epigenetics Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Clin Epigenetics Año: 2020 Tipo del documento: Article País de afiliación: Australia